Hello,
In 2013, FDA came up with a proposed rule to revise medical device and biological product labeling to explicitly allow for the inclusion of stand-alone graphical representation (symbols) provided they are standardized symbols.
1) Can anyone provide input if this rule has been finalized? I could not find any update.
2) In the meantime (if not finalized), is FDA accepting draft labeling as a part of Submissions? Please share your experience with FDA
Thank you
-------------------------------------------
Shiven Gandhi
Regulatory Affairs Specialist
Medtronic
San Francisco CA
United States
-------------------------------------------